Form D · Biotechnology

Embrella Cardiovascular Inc

Wayne, PA · CIK 0001424172

Offering snapshot reported Aug 25, 2009 · SEC filing

Reported sold
$1.5M
Offering amount: $1.5M
Investors reported
2
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Aug 13, 2009
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Aug 25, 2009Initial$1,499,999No comparison2SEC filing
Jun 16, 2009Initial$5,098,991No comparison30SEC filing
Jan 15, 2008PaperNot reportedNo comparisonNot reportedSEC filing

Offering details

Securities
Not reported
Exemptions
06
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-113574

Source: Form D, filed Aug 25, 2009. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Jeffrey Carpenter Director
Jeffrey Carpernter Director
Michael Henson Director
John Kilcoyne Director
John Kilkoyne Director
Renee Masi Director
Jeffrey O'donnell Director, Executive
Jeffrey Valko Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
880 E. Swedesford Road
Wayne, PA, 19087